Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
739.00
+59.00 (8.68%)
At close: Jun 17, 2025, 3:30 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 43.27 billion as of June 18, 2025. Its market cap has decreased by -17.39% in one year.
Market Cap
43.27B
Enterprise Value
28.96B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
739.00
Market Cap Chart
Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 43.27B, a decrease of -85.58%. That is a compound annual growth rate of -29.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 381.06T |
SK hynix | 162.58T |
Samsung Biologics | 72.53T |
LG Energy Solution | 69.26T |
Hanwha Aerospace | 44.59T |
Hyundai Motor Company | 43.49T |
HD Hyundai Heavy Industries | 37.95T |
Kia Corporation | 37.89T |